Case Study

BD – AMR Education and Training Collaboration with the London School of Hygiene and Tropical Medicine (LSHTM)

Company BD, United States
Sub category of Industry Diagnostics
Category of commitment Appropriate Use
Which product(s) Diagnostics
Key focus Education, Stakeholder engagement
Key partners of the program Academia & think tanks, Foundation for Innovative New Diagnostics (FIND), International organizations (e.g. WHO, international NGOs), LSHTM
Geographic focus Africa, China, India, LMICs

BD is collaborating with the London School of Hygiene and Tropical Medicine and other global experts to advance education on the essential role of diagnostics in combatting AMR and strengthening antimicrobial stewardship. The educational materials developed through this collaboration will be accessible as a massive on-line course available to health workers and policymakers globally, and particularly designed to advance capabilities and improve access to diagnostics in low and middle income countries.

Gary M Cohen, Executive Vice President, Global Health and President, BD Foundation

Health needs

Need to build training programs and capacity building for continuous education to help raise awareness of AMR and improve diagnostic utilization.

Initiative’s objective

Develop AMR training curriculum to improve diagnostic stewardship through education and capacity building. Focus will be on education of health professionals worldwide via LSHTM Distance Learning (DL) and on continuing medical education, medical and nursing school training and community based AMR programs.

Initiative’s description

The program is being developed to help educate current and future clinicians on the importance of diagnostics in combating AMR.   Working with LSHTM staff to develop educational, hands-on training modules focused on Healthcare Acquired Infections (HAIs), Tuberculosis, Sepsis, Zoonotic infections, and diagnostics used to reduce the inappropriate use of antibiotics. The curriculum will address WHO priority pathogens list for R&D of new antibiotics. Will expand to other partnerships to establish best practice facilities and strengthen health system capacity in combatting AMR.


The program is design to teach the importance of diagnostics in combating AMR.